Synthesis and Antimicrobial Evaluation of Some Novel Isatin Derivatives
Authors/Creators
- 1. Oriental College of Pharmacy and Research, Oriental University, Indore (M.P.)
Description
Present day challenge of managing microbial infection is ever increasing on account of many factors, out of which emergence of microbial resistance is topmost. Microorganisms are responsible for a number of diseases in human and other animals. As per a report, infectious disease is responsible for 16 million deaths every year worldwide and a lot of these are avoidable. The high level of antimicrobial resistance is a global public health concern. Resistance to potent and effective drugs such as cephalosporins, fluoroquinolones, and carbapenems is a particular concern, as is multidrug resistance. India occupies highest position in the world, in infectious disease list. Antimicrobial agents are considered to be ―miracle drugs‖ that are the leading weapons in combating infectious disease caused by microbes like bacteria, viruses, and fungi. Antimicrobial resistance (AMR), or drug resistance, is the ability of microbes, including bacteria, fungi, parasites, and viruses, to grow in the presence of antimicrobial agent that previously treated them effectively‖. Statistics of World Health Organisation (WHO), show that 490000, people developed MDR-TB, in 2016, globally. The drug resistance is also causing hindrance in fight against HIV and malaria. The study also indicates that people with methicillin resistance Staphylococcus aureus‖ is 64% more proven to death than people infected with non-resistant microbes.
Experts are constantly working hard to devise newer compounds to meet this challenge. Many pharmacophore have the potential as antimicrobial and anticancer agent. Pyrimidine, like Isatin also reported to possess versatile activity such as antimicrobial, anticancer, antifungal, anti-malarial, antiviral and anti-tubercular.
Abstract (English)
Present day challenge of managing microbial infection is ever increasing on account of many factors, out of which emergence of microbial resistance is topmost. Microorganisms are responsible for a number of diseases in human and other animals. As per a report, infectious disease is responsible for 16 million deaths every year worldwide and a lot of these are avoidable. The high level of antimicrobial resistance is a global public health concern. Resistance to potent and effective drugs such as cephalosporins, fluoroquinolones, and carbapenems is a particular concern, as is multidrug resistance. India occupies highest position in the world, in infectious disease list. Antimicrobial agents are considered to be ―miracle drugs‖ that are the leading weapons in combating infectious disease caused by microbes like bacteria, viruses, and fungi. Antimicrobial resistance (AMR), or drug resistance, is the ability of microbes, including bacteria, fungi, parasites, and viruses, to grow in the presence of antimicrobial agent that previously treated them effectively‖. Statistics of World Health Organisation (WHO), show that 490000, people developed MDR-TB, in 2016, globally. The drug resistance is also causing hindrance in fight against HIV and malaria. The study also indicates that people with methicillin resistance Staphylococcus aureus‖ is 64% more proven to death than people infected with non-resistant microbes.
Experts are constantly working hard to devise newer compounds to meet this challenge. Many pharmacophore have the potential as antimicrobial and anticancer agent. Pyrimidine, like Isatin also reported to possess versatile activity such as antimicrobial, anticancer, antifungal, anti-malarial, antiviral and anti-tubercular.
Files
IJPCR,Vol14,Issue11,Article103.pdf
Files
(881.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:03819926d67001c2d6cb318062623638
|
881.8 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-11-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue11,Article103.pdf
- Development Status
- Active
References
- 1. Abbas SY, Farag AA, Ammar YA, Atrees AA, Mohamed AF, El-Henawy AA. Synthesis, characterization, and antiviral activity of novel fluorinated isatin derivatives. Monatsh Chem. 2014; 144(11): 1725-1733 2. Aboul-Fadl T, Abdel-Aziz HA, AbdelHamid MK, Elsaman T, Thanassi J and Pucci MJ. Schiff Bases of Indoline-2, 3- dione: Potential Novel Inhibitors of Mycobacterium Tuberculosis (Mtb) DNA Gyrase. Molecules. 2011; 16: 7864-7879 3. Adibi H, Khodaei MM, Pakravan P, Abiri R. Synthesis characterization and in vitro antimicrobial evaluation of hydrazone and bishydrazone derivative of isatin. Pharm Chem J. 2010; 44: 219- 227 4. Akhaja TN and Raval JP. 1, 3-dihydro2H-indol-2-ones derivatives: Design, Synthesis, in vitro antibacterial, antifungal and antitubercular study. European Journal of Medicinal Chemistry. 2011; 46: 5573-5579 5. Arguelles MCR, Cao R, Deibe AMG, Pelizzi C, Matalobos JS, Zani F. Antibacterial and antifungal activity of metal (II) complexes of acylhydrazones of 3-isatin and 3-(N-methyl) isatin. Polyhedron. 2009; 28: 2187–2195. 6. Atta KF, Farahat OO, Ghobashy SM, Marei MG. Synthesis and Antibacterial Activities of Novel 2,5- Diphenylindolo[2,3-e] Pyrazolo[1',5':3",4"]pyrimido[2",1"-c] [1,2,4] triazines. Molecules. 2011; 16(12):10387-10408 7. Babu KA, Rekha S, Sarita P, Swarnalatha N, Bhavani LR. Synthesis of Nacetyl and N-benzyl isatin Schiff bases and evaluation of their pharmacological actions. J Pharm Res. 2012; 5: 869-872 8. Baharfar R, Asghari S, Rassi S, Mohseni M. Synthesis and evaluation of novel isatin and 5- isatinylidenerhodanine-based furan derivatives as antibacterial agents. Res Chem Intermed. 2015; 41(10): 6975– 6984 9. Baluja S, Bhalodia R, Bhatt M, Vekariya N, Gajera R. Solubility of a pharmacological intermediate drug Isatin in different solvents at various temperatures. International Letters of Chemistry, Physics and Astronomy. 2013; 17: 36-46 10. Bari SB, Agrawal AO, Patil UK. Synthesis and pharmacological and evaluation of some novel isatin derivatives for antimicrobial activity. J Sci Islam Repub. 2008; 19: 217-221. 11. Bogdanov AV, Zaripova IF, Voloshina AD, Sapunova AS, Kulik NV, Bukharov SV, Voronina JK, Vandyukov AE, Mironov VF.Synthesis and Biological Evaluation of New Isatin-Based QACs with High Antimicrobial Potency. Chemistry Select. 2019; 4: 6162. 12. Bogdanov AV, Zaripova IF, Voloshina AD et al. Isatin Derivatives Containing Sterically Hindered Phenolic Fragment and Water-Soluble Acyl Hydrazones on Their Basis: Synthesis and Antimicrobial Activity. Russ J Gen Chem. 2018; 88: 57. 13. Cappucino JG, Sherman N. Microbiology- A Laboratory Manual., California: Addison Wesley; 2014, 10th edn.; 302-305 14. Chinnaswamy RP, Sundrerajan R. synthesis characterization and in vitro antimicrobial activity of some novel 5- substituted Schiff and mannich bases of isatin. J Saudi Chem Society 2013; 17: 337-344. 15. da Silva JFM, Garden SJ and Pinto AC. The Chemistry of Isatins: A Review from 1975 to 1999; J Braz Chem Soc. 2001; 12(3): 273-324. 16. Dabiri M, Salehi P, Baghbanzadeha M and Bahramnejada M. A facile procedure for the one-pot synthesis of unsymmetrical 2, 5-disubstituted 1, 3, 4- oxadiazoles. Tetrahedron Letters. 2006; 47: 6983–6986 17. Dileepan BAG, Daniel Prakash T, Ganesh Kumar A, Shameela Rajam P, Dhayabaran VV, Rajaram R. Isatin based macrocyclic Schiff base ligands as novel candidates for antimicrobial and antioxidant drug design: In vitro DNA binding and biological studies. J Photochem Photobiol B. 2018; 183:191-200. 18. Dua R, Shrivastava S, Sonwane SK, Srivastava SK. Pharmacological Significance of Synthetic Heterocycles Scaffold: A Review, Advances in Biological Research. 2011; 5(3): 120- 144 19. Arellano A., Arellano A., & Arellano D. Gluteoplasty Implants and Lipotransfer Technique. Journal of Medical Research and Health Sciences. 2022; 5(11): 2329–2338. 20. El-Faham A, Elzatahry AA, Al-Othman ZA, Elsayed EA. Facile method for the synthesis of silver nanoparticles using 3-hydrazino-isatin derivatives in aqueous methanol and their antibacterial activity. International Journal of Nanomedicine. 2014; 9: 1167–1174. 21. Farag AA. Synthesis and Antimicrobial Activity of 5-(morpholinosulfonyl) isatin Derivatives Incorporating a Thiazole Moiety. Drug Res. 2014; 65: 373–379 22. Farag AA. Synthesis and Antimicrobial Activity of 5-(morpholinosulfonyl) isatin Derivatives Incorporating a Thiazole Moiety. Drug Res (Stuttg). 2015; 65(7): 373-9 23. Feng LS, Liu ML, Wang B, Chai Y, Hao XQ, Meng S, Guo HY. Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives. Eur J Med Chem. 2010; 45: 3407-3412